SEP 25, 2026 · JOURNAL ARTICLE
Systemic inflammation and prognosis in patients with RAS / BRAF wild‐type metastatic colorectal cancer receiving anti‐ EGFR therapy: A real‐world cohort study
Colorectal Disease
AIM: Colorectal cancer outcomes are heterogeneous, so greater prognostic discrimination is needed. In this retrospective real-world analysis, we assessed the prognostic effect of m